首页> 外文期刊>Virology >Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses
【24h】

Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses

机译:慢病毒载体的假病毒分型使用源自Chandipura和Piry病毒的新型小泡病毒包膜糖蛋白

获取原文
获取原文并翻译 | 示例
       

摘要

While the envelope glycoprotein of vesicular stomatitis virus (VSV-G) is widely used for pseudotyping of lentiviral vectors, sub-optimal gene transfer into certain cell types and its sensitivity to inactivation by human complement hinders its broader applications. To find alternative candidates, here we evaluated two serologically distinct novel viral envelopes derived from Chandipura (CNV-G) and Piry (PRV-G) vesiculoviruses. Both permitted generation of high titer psuedotyped lentiviral vectors with a capacity for high efficiency gene transfer into various cell types from different species. In human lymphoid and hematopoietic stem cells, their transduction efficiency was significantly lower than that of VSV-G. However, both novel envelopes were found to be more resistant to inactivation by human serum complement compared to VSV-G. Thus CNV-G and PRV-G envelopes can be harnessed for multiple uses in the future based on the cell type that needs to be gene transduced and possibly for in vivo gene transfer. (C) 2015 Elsevier Inc. All rights reserved.
机译:尽管水泡性口炎病毒的包膜糖蛋白(VSV-G)被广泛用于慢病毒载体的假型分型,但亚最佳基因转移到某些细胞类型中以及其对人补体失活的敏感性阻碍了其更广泛的应用。为了找到其他候选者,我们在这里评估了来自昌迪普拉(CNV-G)和皮瑞(PRV-G)囊泡病毒的两种血清学独特的新型病毒包膜。两者都允许产生高滴度假型慢病毒载体,该载体具有将高效基因从不同物种转移到各种细胞中的能力。在人淋巴和造血干细胞中,它们的转导效率明显低于VSV-G。然而,与VSV-G相比,发现这两个新的包膜对人血清补体的灭活具有更强的抵抗力。因此,CNV-G和PRV-G包膜可在将来根据需要转导基因的细胞类型用于多种用途,并可能用于体内基因转移。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号